The Cobas e 402 from Roche is an analyser dedicated to immunoassays. Utilizing electrochemiluminescence (ECL) technology, it enables the immunological measurement of multiple analytes in human serum, plasma, or urine with high precision and sensitivity. Depending on the analysis, it employs either the "sandwich" immunometric method or the competitive method, delivering fast and reliable results for a wide range of tests.

Key Features of the Cobas e 402:

• Advanced ECL Technology: The Cobas e 402 uses electrochemiluminescence (ECL) technology, known for its high sensitivity and specificity in detecting various biomarkers. This technology ensures reliable results in fields such as endocrinology, infectious diseases, cardiology, and oncology.
• Speed and Efficiency: The Cobas e 402 offers fast sample processing, delivering results in a short time, improving the overall workflow of the laboratory. It can process up to 86 tests per hour.
• Intelligent Automation: Designed to minimize human intervention, the Cobas e 402 manages the entire analytical process from sample preparation to result generation, reducing the risk of errors and ensuring precise diagnostics.
• Adaptability and Flexibility: The Cobas e 402 supports a wide variety of tests across several medical disciplines, making it versatile and adaptable to the evolving needs of laboratories.

Clinical Applications:

The Cobas e 402 is used for a broad range of diagnostic tests, including screening for infectious diseases, detecting tumor markers, monitoring hormonal disorders, and assessing cardiovascular conditions. Its ability to provide fast and reliable results makes it a key tool for laboratories aiming to enhance their diagnostic capabilities while reducing sample processing time.